Learn More
Cayman Chemical ANTIBODY BZAD-01 5mg

Supplier: Cayman Chemical 387885 MG
An antagonist of NR2B subunit-containing NMDA receptors (Ki = 72 nM); selective for NR2B subunit-containing NMDA receptors over those containing NR2A subunits (IC50s = 47 and >10,000 nM, respectively); reduces carrageenan-induced hyperalgesia in rats (ED50 = 5.5 mg/kg); reduces dopaminergic neuron loss in the rat substantia nigra pars compacta and improves measures of ipsilateral curling, ipsilateral head positioning, and beam walking in a rat model of 6-OHDA-induced Parkinson’s disease at 10 mg/kg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.